Literature DB >> 30526037

Glycans in nanomedicine, impact and perspectives.

Susanna Sampaolesi1, Francesco Nicotra1, Laura Russo1.   

Abstract

Glycans have been selected by nature for both structural and 'recognition' purposes. Taking inspiration from nature, nanomedicine exploits glycans not only as structural constituents of nanoparticles and nanostructured biomaterials but also as selective interactors of such glyco-nanotools. Surface glycosylation of nanoparticles finds application in targeting specific cells, whereas recent findings give evidence that the glycan content of cell microenvironment is able to induce the cell fate. This review will highlight the role of glycans in nanomedicine, schematizing the different uses and roles in drug-delivery systems and in biomaterials for regenerative medicine.

Entities:  

Keywords:  biomaterials; drug delivery; glycans; nanoparticles; regenerative medicine

Mesh:

Substances:

Year:  2018        PMID: 30526037     DOI: 10.4155/fmc-2018-0368

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  5 in total

Review 1.  Embracing nanomaterials' interactions with the innate immune system.

Authors:  Abraham J P Teunissen; Marianne E Burnett; Geoffrey Prévot; Emma D Klein; Daniel Bivona; Willem J M Mulder
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-04-13

Review 2.  Targeting the "Sweet Side" of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis.

Authors:  Nora Bloise; Mohammad Okkeh; Elisa Restivo; Cristina Della Pina; Livia Visai
Journal:  Nanomaterials (Basel)       Date:  2021-01-22       Impact factor: 5.076

Review 3.  Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery.

Authors:  Sergio Andrés Torres-Pérez; Cindy Estefani Torres-Pérez; Martha Pedraza-Escalona; Sonia Mayra Pérez-Tapia; Eva Ramón-Gallegos
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

4.  Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles.

Authors:  Maciej Serda; Robert Gawecki; Mateusz Dulski; Mieczysław Sajewicz; Ewa Talik; Magdalena Szubka; Maciej Zubko; Katarzyna Malarz; Anna Mrozek-Wilczkiewicz; Robert Musioł
Journal:  RSC Adv       Date:  2022-02-22       Impact factor: 3.361

5.  High-throughput chemical and chemoenzymatic approaches to saccharide-coated magnetic nanoparticles for MRI.

Authors:  Thomas W Fallows; Andrew J McGrath; Joana Silva; Simon G McAdams; Andrea Marchesi; Floriana Tuna; Sabine L Flitsch; Richard D Tilley; Simon J Webb
Journal:  Nanoscale Adv       Date:  2019-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.